8-K
XBRL
CURRENT REPORT
- Company
- ORAMED PHARMACEUTICALS INC.
- Filed
- September 26, 2023
- Period of Report
- September 21, 2023
- Accession Number
- 0001213900-23-079586
An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →